Michael Jaglal (USF Health Morsani College of Medicine); (St Georges University)
H Lee Moffitt Cancer Center and Research Institute, Tampa, FL · United States
Editorial leadership for Journal of Hematology and Oncology Research ISSN 2372-6601
Research interests
- Hematology
- Oncology
- Brain Cancer
- Leukemia
Biography
Dr. Michael Jaglal is an oncologist in Tampa, FL and is affiliated with multiple hospitals in the area, including H. Lee Moffitt Cancer Center and Research Institute and Tampa General Hospital. He received his medical degree from St. George's University School of Medicine and has been in practice 12 years. Dr. Jaglal accepts several types of health insurance, listed below. He is one of 169 doctors at H. Lee Moffitt Cancer Center and Research Institute and one of 64 doctors at Tampa General Hospital who specialize in Oncology. He has more than 40 publications and over 450 citings.
Selected publications
- Nivolumab as salvage treatment in a patient with HIV-related relapsed/refractory Hodgkin lymphoma and liver failure with encephalopathy 2017 cited 30×
- Pegylated bovine carboxyhaemoglobin utilisation in a thrombotic thrombocytopenic purpura patient 2017 cited 20×
- Variability in Institutional Guidance for COVID-19-Associated Coagulopathy in the United States 2020 cited 11×
- Complement‐mediated thrombotic microangiopathy treated with anticomplement protein 5 therapy, a retrospective study 2023 cited 2×
- First description of atrial fibrillation and congenital thrombotic thrombocytopenic purpura treated by left atrial appendage occlusion 2023
Ranked by citation impact (Crossref) where available, newest otherwise · verified via ORCID.
Considering JHOR for your work?
This journal is guided by Michael Jaglal (H Lee Moffitt Cancer Center and Research Institute, Tampa, FL) and a peer-review board of practising researchers. Open access, author-retained copyright (CC BY), and a clear editorial process.